Results for tag: "Antimetabolite"

Antimetabolites are a class of immunosuppressive drugs used to prevent the body from rejecting transplanted organs. They work by blocking the metabolism of certain cells, such as those of the immune system, and thus preventing them from attacking the transplanted organ. Antimetabolites are also used to treat autoimmune diseases, such as rheumatoid arthritis and lupus. The antimetabolite market is a rapidly growing segment of the immunosuppressive drug market. It is driven by the increasing prevalence of organ transplantation and autoimmune diseases, as well as the development of new drugs to treat these conditions. Some of the major players in the antimetabolite market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. These companies are actively developing new drugs to treat autoimmune diseases and organ transplant rejection. Show Less Read more